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Abstract 1 
In 2004, a review by the Institute of Environment and Health (IEH) made recommendations 2 
on occupational exposure limits (OELs) for manganese and its inorganic compounds for 3 
inhalable and respirable fractions respectively. These OELs were based on a detailed 4 
comprehensive evaluation of all the scientific data available at that time. Since then, more 5 
published studies have become available and a number of occupational standard-setting 6 
committees (EU SCOEL, US ACGIH-TLV, and Germany MAK) have proposed OEL’s for 7 
manganese and its inorganic compounds that are somewhat lower that those proposed in the 8 
2004 review. 9 
 10 
Based on current understanding, the key toxicological and human health issues that are likely 11 
to influence a health-based recommendation relate to:  neurotoxicology; reproductive and 12 
developmental toxicology; and mutagenicity/carcinogenicity. Of these, it is generally 13 
considered that neurotoxicity presents the most sensitive endpoint. As such, many of the 14 
studies that have been reported since the IEH review have sought to use those 15 
neurofunctional tests that appear to be particularly sensitive at identifying the subtle 16 
neurological changes thought to associate with manganese toxicity. These recent studies 17 
have, however, continued to be limited to a significant extent by reliance on cross-sectional 18 
designs and also by use of unreliable exposure estimation methods. Consequently the 19 
strength of the potential association between manganese exposure and these subtle 20 
subclinical cognitive or neuromotor changes is still poorly characterised and the relevance of 21 
these minor differences in terms of either their clinical or quality of life consequences remains 22 
unknown. 23 
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 24 
Based upon the overall evidence, it is concluded that the 8-hr time weighted averages (TWA) 25 
for respirable (0.05 mg/m3 as Mn) and inhalable (0.2 mg/m3 as Mn) fractions as 26 
recommended by the SCOEL in 2011 are the most methodologically-sound, as they are based 27 
on the best available studies, most suited to the development of health-based OELs for both 28 
respirable and inhalable fractions. The dose-response characterisation informed by the 29 
examined studies used can be considered to establish a true human NOAEL for all the 30 
neurofunctional endpoints examined within the selected studies.   31 
 32 
Keywords 33 
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 35 
 36 
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1 Introduction 38 
The purpose of this paper is to review and describe the development of contemporary 39 
recommended or set occupational exposure limits (OEL) for manganese and its inorganic 40 
compounds by a number of authorative OEL-setting bodies in Europe and the USA. The 41 
process ,as will be shown, is complex as the most informative studies are those using groups 42 
of exposed workers who have been exposed to a range of different manganese compounds 43 
of differing solubility and particle size and measured by different sampling metrics (respirable, 44 
inhalable and total). Unfortunately, airborne exposure of workers cannot reliably be validated 45 
by biological monitoring as, due to the homeostatic control of manganese by the liver, there 46 
is no clear correlation between long-term exposure to manganese and its inorganic 47 
compounds and the biological monitoring of manganese in the urine or blood (Zheng et al. 48 
2011; Laohaudomchok et al., 2011; Gil et al., 2011). To add to this complexity, none of the 49 
worker studies of the subtle neurofunctional (cognitive and motor) effects reported have 50 
used the same battery of tests with a standardised protocol. This makes comparison of the 51 
studies somewhat problematical. 52 
 53 
2 Overview of OEL setting 54 
Occupational Exposure Limits (OELs) have now been a feature of the industrialised world for 55 
many decades. The objective of OELs is to set limits for exposure via the airborne route such 56 
that exposure, even when repeated on a regular basis throughout a working life, will not lead 57 
to adverse effects on the health of exposed persons and/or their progeny at any time (as far 58 
as can be predicted from the contemporary state of knowledge). OELs may be established 59 
using human and/or animal data and are intended to be protective under realistic workplace 60 
  5  
 
exposure conditions (e.g. by mandating controls on the maximum exposure during a working 61 
day or on peak short-term exposures) (EC, 2013). The EU Scientific Committee on 62 
Occupational exposure Limits (SCOEL) advises that OELs may principally be used ‘to provide 63 
standards or criteria against which measured exposure levels in existing workplaces may be 64 
compared in order to ensure that, as far as the current state of knowledge permits, control is 65 
adequate to protect health’. However, OELs can also be used for designing new plants and 66 
processes to ensure that they ‘are engineered in such a way that exposures can be controlled 67 
at levels which will not damage health’ (EC, 2013). In general OELs are used by risk managers 68 
to ensure that workers are not exposed to substances above the OEL whether it is an 8-hr 69 
TWA or 15min STEL. This often results in exposures well under the OEL (guideline or 70 
statutory).  71 
 72 
Various but similar approaches exist for setting OELs and, depending on the particular 73 
socioeconomic, legislative and political environment, different regulatory bodies (e.g. SCOEL1 74 
in the EU, MAK2 in Germany and the American Conference of Governmental Hygienists3 75 
(ACGIH) in the US) may reach somewhat differing conclusions as to what constitutes the 76 
appropriate OEL for a substance.   77 
 78 
2.1 Health based vs. risk based OELs 79 
                                                          
1 http://ec.europa.eu/social/main.jsp?catId=148&intPageId=684&langId=en 
2 http://www.dfg.de/en/dfg_profile/statutory_bodies/senate/health_hazards/ 
3 http://www.acgih.org/tlv-bei-guidelines/policies-procedures-presentations/overview 
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Health based OELs: these are established where the available scientific data base leads to the 80 
conclusion that it is possible to identify a clear threshold dose/exposure level below which 81 
exposure is not expected to lead to adverse effects (EC, 2013). These OELs do not take into 82 
account socioeconomic or achievability factors. 83 
Risk-based OELs: these are established when it is not possible on present knowledge to define 84 
a threshold of activity (e.g. genotoxicity, carcinogenicity and respiratory sensitisation) it must 85 
be assumed that any level of exposure, however small, might carry some finite risk (EC, 2013). 86 
In the EU it is the responsibility of the Commission to set ‘risk-based’ OELs, which requires 87 
consultation with interested parties (EC, 2013). Alternatively, a health-based limit could be 88 
set but socioeconomic and/or achievability are taken into account. In practical terms, this 89 
means that the available data would allow the establishment of a health-based limit but, the 90 
stakeholders (government, trade unions and industry) may negotiate to establish an OEL 91 
above the concentrations(s) of the health-based limit due to socioeconomic or practical 92 
reasons. 93 
 94 
2.1.1 General procedure for setting health-based OELs 95 
For chemicals where a threshold of adverse health effect (immediate or delayed) has been 96 
identified from good quality human and experimental studies, OELs are established by 97 
application of an uncertainty factor (Dankovic et al., 2015) to a point of departure (e.g. 98 
N(O)AEL, L(O)AEL or BMD) for the most sensitive adverse health effect in this case 99 
neurotoxicity. Expert judgement is usually needed by these OEL-setting committees on a case-100 
by-case basis to determine an appropriate uncertainty factor. OELs are established in relation 101 
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to a reference period of 8 hours, for a 40-hour working week and for a working lifetime (8-102 
hour TWA4 OEL) and expressed as ppm  or mg/m3. 103 
 104 
For some threshold chemicals, compliance with an 8-hour TWA does not adequately control 105 
the adverse health effects, and short-term exposure limits (15 min. STELs) are set.  This is 106 
likely to arise for substances for which a critical effect is observed following a brief exposure 107 
(e.g. CNS depression) and where the 8-hour TWA OEL is established at a level not very much 108 
lower than exposures at which there might be a risk of short-term effects occurring.  109 
 110 
In addition, for chemicals where biological monitoring data is available, biological limit values 111 
(BLVs) can be set. These define levels of substances in humans, their metabolite, or indicator 112 
of effect e.g. in blood, urine or breath in workers exposed to the chemical in question at the 113 
level of the OEL. Although biomonitoring provides information about total exposure from all 114 
routes (inhalation, ingestion and dermal), in an occupational setting inhalation is most likely 115 
to be the predominant route of exposure, particularly when considering Mn industries.  . BLVs 116 
do not indicate a sharp distinction between hazardous and non-hazardous exposures. For 117 
many substances, the data are too limited to support a biological monitoring method, or a 118 
metabolite or indicator cannot be defined. 119 
 120 
                                                          
4 TWA – time weighted average for the exposure to a chemical can be used when both the chemical 
concentration and time for exposure varies. For gases the units are in parts per million (ppm) and 
for particulates such as dust, smoke and mist, units are in milligrams per cubic meter (mg/m³). 
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Where data is inadequate to set a BLV, a biological guidance value (BGV) can be established. 121 
This refers to the upper concentration of the substance (or a metabolite) in biological medium 122 
corresponding to a certain percentile (generally 90th or 95th percentile) in a defined 123 
reference population. These values can be helpful in identifying where risk management 124 
measures may be introduced to reduce exposure.  125 
 126 
2.1.2 OEL procedure for non-threshold chemicals 127 
There is growing recognition that carcinogenic risk extrapolation to low doses (and standard 128 
setting) must consider the mode of action of a given chemical. To date there is a general 129 
agreement to distinguish between genotoxic and non-genotoxic chemicals, but further 130 
differentiation based on mode of action also seems appropriate (Bolt & Huici-Montagud, 131 
2008). This means that a threshold approach may be applied for some carcinogens. In the EU, 132 
SCOEL distinguishes 4 types of carcinogen on mechanistic grounds, namely:  133 
Group A: Non-threshold genotoxic carcinogens - for low-dose risk assessment linear non-134 
threshold (LNT) modelling is applied;  135 
Group B: Genotoxic carcinogens – where a threshold cannot be sufficiently established, LNT 136 
modelling is used as a default assumption;  137 
Group C: Genotoxic carcinogens - for which a practical threshold is supported; and 138 
Group D: Non-genotoxic carcinogens and non-DNA reactive carcinogens - a true threshold 139 
may be established associated with a NOAEL. 140 
 141 
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SCOEL seeks to derive health-based OELs for carcinogens in Groups C and D and, if possible, 142 
apply risk-based assessments to Category A and B substances (Bolt & Huici-Montagud, 2008; 143 
Bolt et al,  2004; EC, 2013). 144 
 145 
2.1.3 Additional notations 146 
In addition to recommending an 8hr TWA and 15 min. STELs, OEL-setting committees also use 147 
additional notations, where appropriate, to assist in risk management decisions; these 148 
include, skin notation, respiratory sensitisation and noise. In the case of the latter notation, 149 
there is evidence that demonstrates a link between certain organic solvents and excessive 150 
noise in the workplace, leading to hearing loss in workers (Unlu et al., 2014). 151 
 152 
3. Occupational exposure to manganese 153 
The world-wide mine production of manganese ore was estimated by the US Geological 154 
Survey to be around 18 million metric tonnes in 2014. Of that, 61% was produced in the 155 
Gabon, 16% in Australia, 14% in South Africa, 4% in Ghana, and 5% in a number of other 156 
countries (USGS5).  157 
 158 
The main uses of manganese continue to be for the production of alloys (ferrous and non-159 
ferrous), particularly in the steel making industry, and it is estimated that around 89% to 94% 160 
                                                          
5US Geological Survey (USGS);http://minerals.usgs.gov/minerals/pubs/mcs/2015/mcs2015.pdf 
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of manganese ore is used as feedstock for manganese alloys (CPM, 2011). The remaining 161 
manganese ore is used in foundry and welding, accounting for less than 10% of manganese 162 
ore (CPM, 2011). It is estimated that 6% to 11% of manganese ore is used in the production 163 
of electrolytic manganese metal (EMM), electrolytic manganese dioxide (EMD), lithium 164 
manganese oxide, manganese sulphate, and other chemicals. As noted above, the key 165 
metallurgical uses of manganese are in steel, aluminium and copper, while the key non-166 
metallurgical uses of manganese are in batteries and agricultural feed and fungicides. 167 
 168 
A review of workplace exposure to manganese was carried out by the Institute of 169 
Environment and Health (IEH) in 2004, and reported within a Criteria Document6 produced 170 
for the International Manganese Institute (IMnI). The review found that there was substantial 171 
variability in exposure levels to manganese both between and within individual industry 172 
sectors. The three sectors for which most data were available were mining, manganese metal 173 
and alloy production and battery manufacture. The highest and most variable exposures were 174 
in mining with a maximum concentration (arithmetic mean) of 114 mg/m3 as manganese in 175 
total dust reported for miners in an Iranian study (Boojar and Goodarzi, 2002). In comparison, 176 
the highest exposure concentration reported in a study of South African miners in a modern 177 
mine was 1.5 mg/m3 (Myers et al., 2002). These two studies, although contemporaneous, 178 
show very large differences in exposure levels. This must be largely due to differences 179 
between modern high technology mining operations using efficient control measures, such 180 
as use of water sprays, good ventilation, and isolation of workers from sources of dust, and 181 
                                                          
6 Available at: http://www.iehconsulting.co.uk/IEH_Consulting/IEHCPubs/HumExpRiskAssess/w17.pdf 
 
  11  
 
what must be assumed to be older, less controlled methods of extraction. Some high 182 
exposures were also reported for manganese metal and manganese alloy production with a 183 
maximum exposure concentration of 27 mg/m3 (inhalable) reported in a Norwegian smelter 184 
(Johnsen et al. 2010) though typical levels were much lower (geometric mean = 0.254 mg/m3).  185 
Exposure concentrations associated with battery manufacture ranged up to 11 mg/m3 as 186 
inhalable manganese in a Belgian study (Roels et al., 1992). 187 
 188 
Importantly, the IEH review (IEH, 2004) specifically examined information about the 189 
concentrations of manganese in different size fractions, to derive conversion factors that 190 
could be used to assist in the interpretation of epidemiological studies in which different 191 
fractions of manganese in air had been measured (respirable, inhalable or total dust). The 192 
authors concluded that only a small proportion of inhalable manganese was of respirable size, 193 
although this varied by process (with exception of welding). A conversion factor of 1.2-3.2 194 
was proposed to convert ‘total’ to ‘inhalable’ concentrations and a factor of 0.1-0.5 to convert 195 
‘total’ concentrations to equivalent ‘respirable ‘concentrations (to allow cross study 196 
comparison). 197 
 198 
The IEH review (IEH, 2004) also assessed the limited biological monitoring data that was 199 
available at the time of publication. The data showed considerable interindividual variability 200 
in blood manganese levels, although manganese exposed workers generally had higher blood 201 
manganese than unexposed. The data did not however, establish a clear relationship between 202 
exposure concentrations of manganese in air and blood manganese, and there was little 203 
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evidence to support the use of blood manganese as a reliable exposure index. Over the range 204 
of studies reviewed, urinary manganese levels also varied substantially, even among the 205 
controls, however, almost all of the studies reported significant differences between controls 206 
and exposed workers. No clear relationship between airborne exposure and urinary levels on 207 
an individual basis was demonstrated. 208 
 209 
3.1 OEL setting for manganese 210 
In their review of the literature regarding occupational exposure to manganese in 2004, the 211 
IEH proposed OELs of 0.1 and 0.5 mg Mn/m3 for respirable and inhalable fractions 212 
respectively. Consideration of the levels and duration of exposure in the studies by Gibbs et 213 
al. (1999) and Myers et al. (2002), which found no neurological effects in exposed workers, 214 
and the study by Roels et al. (1992), which showed adverse neurological effects, was used as 215 
a basis for determining a NOEL and the proposed OELs; these were considered protective 216 
based on knowledge at the time.  217 
 218 
However, an updated search of studies and reviews around the exposure and uptake of 219 
manganese and of neurotoxic effects in workers, published subsequent to the IEH 2004 220 
review (as detailed in Appendix A), suggest that some non-clinical neurofunctional adverse 221 
effects may be occurring around the OELs proposed by the IEH 2004 review. 222 
 223 
3.1.1Availability of robust exposure data 224 
  13  
 
For OEL setting, as in all risk assessments, often the weakest component of key occupational 225 
studies for manganese has been the exposure assessment, which is as important a 226 
consideration as the toxicological health outcome. For manganese, cross study comparisons 227 
of data also remain limited by the variable approach taken to sampling by the authors.  228 
 229 
A number of investigators have reported exposure measurements for the respirable, 230 
total/inhalable or other size fractions of manganese which are expected to have different 231 
bioavailabilities (ATSDR, 2012). The particle size of inhaled manganese would be anticipated 232 
to affect uptake and distribution and it is conventionally assumed that a much higher 233 
absorption of inhaled material in the respirable fraction is deposited in the lungs than of 234 
coarser material, which is largely swallowed. Several studies provide information about 235 
particle size in individual workplace environments (Ellingsen et al., 2003; Harris et al., 2005; 236 
Pearson and Greenway, 2005; Berlinger et al., 2007; Michalke et al., 2007; Berlinger et al., 237 
2008; Ellingsen et al., 2008; Ross et al., 2009; Keane et al., 2010; Lehnert et al., 2012). As 238 
would be anticipated, there are substantial differences in the size distribution of airborne 239 
manganese in different workplace environments with processes that generate fume giving 240 
rise to aerosols with a much higher respirable content (as a percentage of total/inhalable 241 
manganese) than activities such as breaking up ore or cutting manganese containing 242 
materials. However, the ratio of respirable to inhalable Mn in workplace air is generally in the 243 
range 0.1-0.5. 244 
 245 
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A further issue for manganese regarding exposure monitoring methodology is the 246 
unexplained variability observed in mean blood manganese levels reported for non-exposed 247 
controls in workplace studies, as well as in studies of the general population.  Currently, 248 
therefore, it is not clear whether real differences in mean blood manganese levels exist 249 
between different population groups; potential causes for such differences could include 250 
factors such as dietary intake of manganese and iron. Alternatively, the differences may arise 251 
from differences in measurement protocols, including the sampling regimes adopted by the 252 
authors as it was notable in the identified literature that the validated NIOSH methods for 253 
metals in urine and blood were not widely used. 254 
 255 
Significant exposure via the skin is unlikely in most workplaces where manganese is present 256 
as the nature of the tasks being undertaken means that workers are likely to be wearing 257 
gloves and protective clothing and there is limited potential for direct skin contact to occur.  258 
Inadvertent ingestion is most likely to arise in individuals with poor personal hygiene, 259 
particularly where there are no strict procedures to ensure that workwear is removed and 260 
exposed skin washed prior to breaks in the working day and at the end of the work shift (IEH, 261 
2004). 262 
 263 
3.1.2 Assessment of available neurotoxicity data 264 
In their review, the IEH (IEH, 2004) noted that the available evidence at the time of publication 265 
indicated that subtle subclinical neurological effects in humans were the most critical 266 
endpoint associated with chronic low-level occupational exposure to manganese. This is 267 
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suggested to be linked to the accumulation of manganese in brain tissue following inhalation, 268 
with the basal ganglia region being a primary target of toxicity. These changes were, and still 269 
are, considered a suitable basis for setting an OEL. Indeed there is a reasonable body of 270 
evidence from human cohort studies that occupational manganese exposure may induce 271 
subtle neurotoxic changes and that current occupational levels of manganese may be 272 
associated with the onset of some symptoms of manganism (EC, 2011; ATSDR, 2012).  273 
 274 
Whilst there is a growing body of evidence that occupational exposure to manganese at levels 275 
below those associating with the onset of manganism may elicit subtle neurofunctional 276 
perturbations (Meyer-Baron et al., 2009 and 2013), such changes are only detectable using 277 
specialised testing and represent sub-clinical effects. Studies that support the existence of 278 
such an association are subject, to varying extent, to methodological limitations. However, 279 
recent work has strengthened the evidence base that there is a lack of progression (or, in 280 
some cases, regression) of the subtle changes once the occupational exposure is reduced or 281 
stopped (Bouchard et al. 2007b and 2007c; Wastensson et al, 2012).  Furthermore, there is 282 
now a possible explanation for the varying levels of recovery observed, with evidence 283 
suggesting that different brain loci may show varying degrees of susceptibility and recovery 284 
potential (Bowler et al., 2011).   285 
 286 
Many of the studies that have been reported since the IEH review (IEH, 2004) have sought to 287 
use those neurofunctional tests that appear to be particularly sensitive at identifying the 288 
subtle neurological changes thought to associate with manganese toxicity. These recent 289 
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studies have, however, continued to be limited to a significant extent by continued reliance 290 
on cross-sectional designs and also by use of potentially unreliable exposure estimation 291 
methods. Consequently the strength of the potential association between manganese 292 
exposure and these subtle subclinical cognitive or neuromotor changes is still poorly 293 
characterised and the relevance of these minor differences in terms of either their clinical or 294 
quality of life consequences remains unknown (SCOEL, 2011; ACGIH, 2013). 295 
 296 
3.2 Current and proposed OELs for manganese 297 
Since the OELs were proposed in the review by the IEH (IEH, 2004) there has been much 298 
activity around the setting of OELs for manganese by a number of the key OEL setting bodies. 299 
In addition, the EU SCOEL has published recommendations for OELS for manganese and its 300 
inorganic compounds7. Table 1 shows current OELs from the OEL setting bodies, with the OELs 301 
proposed by the IEH in 2004 included for comparison. It should be noted that the recent 302 
evaluations of the SCOEL, MAK and the ACGIH suggest that it may be possible to establish 303 
reliable health-based OELs for neurofunctional changes which can be considered true NOAELs 304 
for these effects. 305 
 306 
 307 
 308 
                                                          
7It should be noted that at the time of writing, this recommendation has not yet passed though the EU DG 
Employment, Social Affairs and Inclusion’s appropriate committee procedures and thus, it is not known whether 
the document and its recommended OELs will be accepted or modified. 
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 309 
 310 
Table 1. Current and proposed OELs for manganese 311 
 Respirable OEL                              
(mg Mn/m3) 
Inhalable OEL                               
(mg Mn/m3) 
IEH (2004) 0.1 0.5 
OEL Setting Committees 
SCOEL IOELV  (2009 - 2011) 0.05 0.2 
MAK Commission (2010)                   0.02 0.2 
ACGIH TLV-TWA (2011 - 2013) 0.02 0.1 
IEH – The Institute of Environment and Health; SCOEL – The Scientific Committee on Occupational Exposure 312 
Limits; IOELV – indicative occupational exposure limit value; MAK - Permanent Senate Commission for the 313 
Investigation of Health Hazards of Chemical Compounds in the Work Area (Germany); ACGIH -  The American 314 
Conference of Governmental Industrial Hygienists ; TLV-TWA - Threshold Limit Value–Time-Weighted Average. 315 
 316 
The derivation of each of these OELs is discussed below, with details of individual studies 317 
given in Table 2. 318 
 319 
3.2.1 The Scientific Committee on Occupational Exposure Limits 320 
The Scientific Committee on Occupational Exposure Limits (SCOEL) recommendations note 321 
that there is a substantial literature on the effects of manganese on the human nervous 322 
system and that high exposures can result in severe neurotoxic signs and symptoms, some of 323 
which resemble those of idiopathic Parkinson’s disease. It concludes the clinical symptoms 324 
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associated with manganism, such as movement disorders and neurological dysfunction, have 325 
generally been reported at exposure levels above 5 mg/m3. However, it noted that more 326 
recently, several studies on lower occupational exposures to manganese have reported less 327 
severe, subtle, non-clinical neurofunctional effects. These subtle effects usually consist of 328 
deterioration in motor function and co-ordination and, as such, may constitute manganese-329 
induced changes in the same area of the brain as manganism, that is the basal ganglia and, in 330 
particular, the globus pallidus. 331 
 332 
In their findings, SCOEL state that it was not possible to identify one study on which to base 333 
the IOELVs as the data is highly heterogeneous (e.g. different types of industry, different 334 
manganese compounds and particle sizes, different study designs and different 335 
neurofunctional measurements). They recommended a global approach using the most 336 
methodologically-sound studies (i.e. showed adverse neurological effects and identified a 337 
point-of-departure (POD) in the dose-effect/response relationship), as used by IEH (2004). 338 
The SCOEL Recommendation, based on studies by (Roels et al., 1992; Gibbs et al., 1999; Myers 339 
et al., 2003; Young et al., 2005; Bast-Pettersen et al., 2004; Ellingsen et al., 2008; Lucchini et 340 
al. 1999 in HC, 2008) was thus as follows: 341 
“A reasonable respirable IOELV of 0.05 mg/m3 can be recommended, and a reasonable 342 
inhalable IOELV of 0.2 mg/m3 is also recommended. While recommending these values, 343 
SCOEL recognises that the overall systemic absorption of coarser particles (>respirable) is 344 
probably substantially lower than for the respirable fraction. Thus, SCOEL recommends both 345 
a respirable and an inhalable IOELV which would need to be observed conjointly”. 346 
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SCOEL are thus drawing attention to the fact that these recommended values were highly 347 
precautionary and would protect against any neurofunctional change. Indeed, SCOEL noted 348 
that the changes reported are subtle early neurofunctional effects which are non-clinical in 349 
nature and are only detected at a statistical level between groups of workers. In addition, 350 
some of the subtle neurofunctional effects of manganese on the CNS are reversible although 351 
the degree of reversibility has not been defined. 352 
 353 
In addition to these airborne IOELVs, SCOEL agreed with the views on biological monitoring 354 
in the 2004 CD (IEH, 2004) on which the SCOEL/SUM is mainly based. That it was not possible 355 
to recommend a health based biological monitoring standard due to the poor correlation 356 
between airborne manganese and either blood or urine concentrations of manganese. 357 
However, they noted that in Germany, a Biologischer Arbeitsstoff-Referenzwert (BAR) value 358 
of 15 μg/l blood has been established by the MAK Commission. This value represents 359 
manganese concentrations in the general population (95thpercentile) not occupationally-360 
exposed to manganese, but of working age (EC, 2011). 361 
 362 
3.2.2 The Permanent Senate Commission for the Investigation of Health Hazards of 363 
Chemical Compounds in the Work Area  364 
The Permanent Senate Commission for the Investigation of Health Hazards of Chemical 365 
Compounds in the Work Area (MAK Commission) in Germany revised their MAK values for 366 
manganese and its inorganic compounds in 2010. They followed the recommendations of the 367 
IEH (IEH, 2004) with regards to setting values for both respirable and inhalable fractions. 368 
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Although a comprehensive evaluation, they noted that “as toxic effects on the airways and 369 
lungs (so-called manganese pneumonia) after repeated exposure to manganese are not 370 
induced below concentrations of at least 1 mg/m3 (IEH 2004), its neurotoxic effects will be 371 
used for derivation of the MAK value”. They thus concentrated almost entirely on human 372 
neurofunctional investigations and classified these studies into those to be considered for 373 
OEL setting, for inhalable and respirable fractions separately, which met the following criteria 374 
(Category A studies): exposure to manganese at the workplace by inhalation, application of 375 
standardised neuropsychological test procedures, parallel investigation of a non-exposed 376 
control group, valid data on manganese concentrations in the ambient air, as well as the 377 
control of major confounders. Studies that did not meet all criteria were assigned as Category 378 
B, with studies of welders assigned to Category C. The derivation of the MAK value was 379 
established on the basis of studies in Category A, with those in Categories B and C used as 380 
supporting evidence (Chia et al., 1993; Lucchini et al., 1999; Mergler et al., 1994; Gibbs et al., 381 
1999; Young et al., 2005; Myers et al., 2003; Bast-Pettersen et al., 2004; Meyer-Baron et al., 382 
2009). 383 
 384 
As with other recently-active OEL-setting committees, the MAK considered that the most 385 
sensitive endpoint for deriving workplace threshold concentrations for manganese was the 386 
occurrence of preclinical neurotoxic effects after inhalation. They examined in detail exposure 387 
with measurements in motor and cognitive function and looked for concordance between 388 
studies. For the derivation of a MAK value based on neurofunctional toxicity data, the MAK 389 
stressed that it needs to be shown that (a) no single effect is involved in only one study, (b) 390 
different studies provide evidence of a similar effect at comparable dose ranges, (c) the 391 
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observed performance impairments are compatible with the proposed neurotoxic 392 
mechanisms and (d) the impairments in performance observed can be seen as indicators of 393 
clinical changes in exposures either extremely high or lasting for many years. If these 394 
prerequisites are met in the case of manganese, the impairments in performance are to be 395 
classified as adverse effects, as they constitute early signs of clinically-relevant changes.  396 
 397 
They also stress that in deriving a MAK value from epidemiological cross-sectional studies, 398 
unlike animal investigations, no direct derivation of a NOAEC or LOAEC is possible, as only an 399 
average value is available for manganese exposure in the exposed group.  400 
3.2.3 The American Conference of Governmental Industrial Hygienists  401 
The American Conference of Governmental Industrial Hygienists (US ACGIH) have had a 402 
number of Draft notices of intended changes (NIC) for manganese, elemental and inorganic 403 
compounds, published over the last few years, with a final accepted version being published 404 
in 2013 (ACGIH, 2013). It is important to note that ACGIH also propose both respirable and 405 
inhalable values.  406 
 407 
In the development of their recommendations, the ACGIH first cite the study by Roels et al. 408 
(1992) which proposed that a respirable OEL of 0.036 mg Mn/m3 would protect most workers 409 
from neurological effects. Further analysis of this study data by the ATSDR (ATSDR, 2012) 410 
using a benchmark dose approach, allowed the ACGIH to calculate a BMDL10 of 0.07 mg 411 
Mn/m3 as a NOAEL.  412 
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 413 
In their recommendation, the ACGIH also noted the analysis by Crump and Rousseau (1999) 414 
of the follow-up study by Roels (1987) which showed that after 11 years further exposure to 415 
Mn, there was some evidence that the previously reported sub-clinical neurological effects 416 
were not progressing. Next, they cited the study by Mergler et al. (1994) in which workers 417 
were exposed to a median level of 0.032 mg Mn/m3 (respirable). The workers in this study 418 
were examined 14 years following cessation of exposure and it was noted that some of the 419 
previously reported neurobehavioural changes were still persisting (Bouchard et al. 2007a 420 
and b). The study by Lucchini et al. (1999) showed an LOAEL for neurological effects of about 421 
0.1 Mn/m3 (total dust) after an average of 11.5 years. This corresponded to a respirable 422 
geometric mean concentration of 0.036 mg Mn/m3. 423 
 424 
The ACGIH noted that the Bast-Pettersen et al. (2004) study reported tremor (impaired hand 425 
steadiness) at a geometric mean level of 0.036 mg/Mn/m3 (respirable), whilst in a study on 426 
South African manganese smelters, Young et al. (2005) showed increased neurobehavioural 427 
changes in workers exposed to 0.01-0.04 mg Mn/m3 (respirable).  428 
 429 
In developing the rationale for their TLV, the ACGIH noted that the LOAELs for neurological 430 
effects derived from the studies of Bast-Pettersen et al. (2004), Lucchini et al. (1999), Mergler 431 
et al. (1994) and Roels et al. (1992) which are respectively, 0.036, 0.032, 0.038 and 0.036 mg 432 
Mn/m3 (respirable) are in close agreement. Thus, a TLV-TWA of 0.02 mg Mn/m3 respirable 433 
particulate matter was recommended for manganese and its inorganic compounds “to 434 
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reduce the potential for preclinical, neurophysiological and neuropsychological effects in 435 
manganese-exposed workers.” It was noted by the ACGIH that this value is 1.5-2.0 times lower 436 
than the range of LOAELs observed. 437 
 438 
However, the ACGIH also stated that in some occupational situations, exposure to manganese 439 
was to aerosols with a substantial fraction greater than 4 µm MMAD (respirable range) and 440 
thus a supplementary TLV-TWA of 0.1 mg Mn/m3 inhalable particulate matter was 441 
recommended for conditions where particles >4 µm are anticipated. They note that the ratio 442 
of inhalable to respirable mass may vary from 1:1 to 10:1 but, have used a  midpoint ratio for 443 
conversion of 5;1, and cited the previous IEH Criteria Document (IEH 2004 ), which also gave 444 
this ratio, in support of their approach. They finally note that if the inhalable TLV-TWA is used, 445 
then this should be in addition to the respirable TLV-TWA. 446 
 447 
3.3 Assessment of key studies used for derivation of OELs 448 
As discussed previously, often the weakest component of key studies has been the exposure 449 
assessment, which is as important as the toxicological health outcome. In the case of 450 
occupational exposure to manganese and its inorganic compounds, usually the 451 
neurofunctional tests although very variable and many without defined normative data, have 452 
been reasonably well described and with the use of appropriate control groups. However, in 453 
many cases the studies have contained unreliable estimates of long-term exposure often 454 
based upon limited exposure data. 455 
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 456 
An outline of the studies that have been included in the derivation of OELs by the IEH (IEH, 457 
2004) and the OEL setting bodies, SCOEL, MAK and ACGIH is given in Table 2.  In assessing 458 
these studies, one of the key considerations must be the reliability of the exposure 459 
assessments undertaken and what influence that may have on the overall OEL. 460 
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Table 2 Critique of exposure assessment in studies consideredby OEL setting committees to derive OELs for manganese and its inorganic compounds 
Study Author Included in OEL derivation Comments on Exposure Assessment 
Lauwreys et al., 1985 IEH 2004 Only current (not historical) exposure data available. Exposures ranged from 1-19 years 
(mean 7.9), 8 hour TWA ranged from 0.07-8.61 mg/m3 (arithmetic and geometric mean 
values 1.33 and 0.94 mg/m3 respectively) – 80 samples – authors indicated that past 
exposures may have been lower as production rates were lower (however industrial 
hygiene has generally improved through time), fertility effects only examined for exposed 
group as a whole, not in relation to relative current exposure levels or any sort of 
cumulative exposure index (CEI). 
Critique: study considered not helpful to establishing an OEL. 
Roels et al., 1992 IEH 2004; EC 2011; ACGIH 2013 Personal measurements of respirable and inhalable exposures to Mn.  Inhalable 
measurements based on grit pots in cyclone samplers which is not an approved sampling 
method. Cumulative exposure estimated on basis of current exposure levels and job history 
- some potential to under-estimate cumulative exposure, if exposures were less well 
controlled in the past however, specific statement to effect that work processes have not 
been modified over previous 15 years is included and measurements would therefore be 
expected to be representative of past exposure. 
Exposure response relationship illustrated for lifetime cumulative exposure as a continuous 
variable in a non-threshold model, and also for exposure categorised as <600, 100-1200, 
>1200 ug Mn/m3.years with apparent effects in <600 group - nothing to pinpoint a 
threshold. The upper bound estimated ED05 level of the investigated endpoints were 3575 
ug Mn/m3.year total and 730 ug Mn mg/m3.year respirable - these levels are subsequently 
described as threshold for effects. 
Critique: study did not use an approved sampling method which may impact on exposure 
estimates. 
Mergler et al., 1994 ACGIH 2013 Static samples at 13 representative locations through facility, sampling and analytical 
procedures described, no QC details – may not be closely related to actual personal 
exposure; total and respirable Mn measured. Only 38 samples were collected – not many 
to characterise exposure across workplace and no evidence that investigators tried to 
establish levels of exposure associated with different job functions.  It is stated that dust 
levels had previously been much higher.   
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Critique: the relationship between MnAir and neurobehavioural effects does not appear 
to have been investigated and the study is not helpful to the setting of an OEL 
Gibbs et al., 1999 
 
 
IEH 2004; EC 2011 Current  (1997) respirable and total concs of Mn were measured for  12 job categories (not 
given) and arithmetic mean used to estimate pre-1997 exposure levels for each job 
category, taking account of process and work practice changes and the results of 15 minute 
compliance samples collected before and after such changes. Job histories derived from 
personnel records, interview and pay roll records and used to calculate cumulative 
exposures. The sampling and analysis procedures are described but no QC information 
provided.  The number of samples collected does not appear to be stated and there is no 
information about the variability of the exposure estimates for each job category. There is a 
small uncertainty around the back projection of exposure concentrations from 1997 
measurements – possibility that past exposures could be under-estimated.  Results of 
neurobehavioural tests assessed against previous 30 days, years and lifetime exposure – 
treated as continuous variable – no artefacts associated with grouping of exposures. 
Critique:  It is not certain how much confidence to ascribe to the exposure estimates. 
Lucchini et al., 1999 IEH 2004; EC 2011; Health Canada 2012; 
MAK 2010; ACGIH 2013. 
Air sampling performed 1 month before neurobehavioural testing, respirable and total Mn 
concentrations determined using personal and stationary sampling – methods are 
described, no QC details, Cumulative exposure index (CEI) calculated by multiplying average 
annual airborne Mn concentration characteristic of each job performed by the subject 
during his work history and years exposed with adjustment for inhalation rate for different 
task workloads.  No adjustment made for any changes in work practice – possible that 
measured exposures would be less than historic exposure concentrations. MnB and MnU 
determined for samples collected at time of nuerobehavioural test.  Plot of CEI and MnB 
indicates an apparent relationship – no information is provided as to the relationship 
between CEI and current exposure levels or MnB and current exposure levels.   
Critique: the neurobehavioural test results are not analysed in relation to MnAir or CEI, so 
the paper is not informative about the exposure levels that give rise to effects versus 
those that don’t – some effects seen in a group with current exposures that range from 
0.026-0.75 mgm-3 as total Mn. Unlikely to be helpful in setting an OEL. 
Crump & Rosseau , 1999 IEH 2004 No Mn Air data and results not assessed in terms of cumulative exposure to Mn – could be 
assumed that air Mn concentrations similar to those described by Roels et al., in earlier 
study at same plant. 
Critique: overall not helpful to setting an OEL – confirms previously described levels of 
exposure at plant have adverse effects but not enough to derive a NOAEL or LOAEL. 
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Myers et al., 2002 IEH 2004 Base-line cross-sectional study in miners working in deep mining and opencast. Largest 
study, modern technology. Well conducted and described. Inhalable fraction = 1.4 times 
total dust. No correlation between MnA andMnB. 
Critique: good quality exposure data recorded. 
Clewell et al., 2003 ACGIH 2012 Calculation of BMD for datasets underlying Roels et al., (1992) and Gibbs et al., (1999) 
studies. Some approximations required to derive exposure concentrations for individual 
workers. Analysis based on current exposure concentrations (based around arithmetic 
mean), given the likely interindividual variability in exposure in each exposure group, there 
could be significant under or overestimates of exposure at an individual level) – CEI was not 
investigated (which seems a major weakness). 
Critique: the elegance of presentation hides considerable uncertainty in the most 
appropriate way to handle the exposure data. 
Myers et al., 2003a  EC 2011;  Exposure assessment based on measurements made to meet regulatory requirements with 
some additional measurements made to confirm reliability of routine measurements. 
NIOSH methods of analysis - no detail on QC but no reason to anticipate that data would 
not be reliable. Measurements made for individuals representative of task being assessed - 
data collected over 4 years - should have a reasonable long term average TWA for each 
occupational group. Individual mean and cumulative exposure assessments made by 
multiplying concentration for each job times years worked in that job and average 
exposure intensity and average exposure intensity calculated from cumulative exposure 
divided by service life.  Exposure treated as a continuous variable in analysis of exposure-
response relations. 
Critique: unsure how representative measurements are of historical exposure which may 
have been higher. 
Myers et al., 2003b  MAK 2010;  Analytical methods and QC well described, but time period over which sampling conducted 
not given. 
Critique: implication that exposure assessment based on a snapshot of exposure 
concentrations rather than being representative of long term mean exposure levels. 
Bast-Pettersen et al., 2004 ACGIH 2013; EC 2011 Mn Air - personal full shift sampling for 3 days for each individual on days close to their 
neuopsychological examination. No information about long term variation in individual 
exposure levels. Urine and Blood samples taken. Exposure data treated as continuous 
variable. Plots of data as groups with differing duration of exposure. Data examined against 
low, medium and high MnB. Critique: exposure data may be unrepresentative of past 
exposures - potential for effects of exposure to low concentrations to be over-estimated. 
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Young et al.,  2005 BD 2013; EC 2011; ACGIH 2013 Related to Myers (2003b) smelter study - not sure whether same source of exposure data. 
310 inhalable dust concentrations, 98 personal dust concentrations - suspect single 
measurement campaign - not clear whether representative of historical exposure levels - 
cumulative exposure indices developed but then divided by duration of exposure to give 
average intensity. Study focussed on respirable Mn - estimation of respirable Mn where 
gaps in job exposure measurement. Link given to more detailed description of how 
exposure estimates were derived is broken.  
Critique: response examined by exposure category by average intensity of exposure 
rather than cumulative exposure - so issue of whether central tendency, upper or lower 
bound concentration most relevant plus issues of whether cumulative exposure and/or 
peak exposures more relevant. Authors state that only the intensity groupings presented 
as cumulative exposures gave similar results - which seems surprising. 
Ellingsen et al.,  2008 EC 2011 Details of sampling and analysis in Ellingsen et al (2006). Sampling conducted as a single 
survey- blood and urine samples for 96 welders - 180 air samples collected on preceeding 2 
days for each welder providing biological samples, QC for analysis described, evidence of a 
methodological approach to the sampling.  
Critique: no information about day to day variability of the exposure of any individual - 
measurements reflect average for group; analysis examined MnB, MnAir and duration of 
exposure but not cumulative exposure. Exposure data may be unrepresentative of past 
exposures - potential for effects of exposure to low concentrations to be over-estimated. 
No information that would confirm MnB, MnAir for individuals that were used in the 
analysis were actually representative of long term exposure for those individuals. The 
study tells you about the average level of neurobehavioural impairment versus an 
average cumulative exposure as MnAir but is not going to provide reliable dose-response 
information beyond that - the determination of MnAir, however, is likely to be reliable. 
Meyer-Baron et al., 2009         
(meta-analysis) 13 studies 
included: 
 
Bast-Pettersen et al.,  2004 
 
MAK 2010 
 
 
 
 
 
 
 
See above 
Blond &Netterstrom, 2007; 
Blond et al., 2007 
 
 No details given of how Mn measurements made. Dust measurements made in 1970s 
varied from 0.7-62.2 mg/m3 as total dust, Mn 1-3%, Mn in air assumed to have been 
between 0.01 and 1.9 mg/m3, median 1.1 mg/m3. Personal and static measurements of Mn 
made in 1990s - personal inside airfed helmets, static outside, much higher, stated that 
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compliance with use of air fed helmets was <100% - total Mn 0.01-0.84 mg/m3, median 
0.03. Median PbB in 1989 was 0.79 umol/l = <2 ug/dL.  
Critique: comparison made between exposed and unexposed groups - no exposure 
response information in terms of threshold of effects, contribution of higher levels of 
historical exposure or consideration of cumulative exposure.  
 
Chia et al., 1993 
 
  
Regular annual monitoring of exposure had been undertaken for many years – personal 
samples for a representative selection of workers. Neurobehavioural effects not considered 
in relation to airMn or CEI – air monitoring results show steep decline in air Mn through 
time – so workers received historical exposures that were vastly greater than those 
experienced at the time of the study.  
Critique: study not informative about relationship between air Mn and neurobehavioural 
effects. 
 
Ellingsen et al.,2008 
 
 See above 
Lucchini et al., 1997 
 
 Exposures quoted as total dust. No differentiation by job function or location reported. 
Critique: Well-conducted study but small sample size and lacking detail. 
. 
Mergler et al., 1994 
 
 See above 
Myers et al., 2003a 
 
 See above 
Roels et al., 1992 
 
 See above 
Roels et al., 1987 
 
 Cumulative exposure unable to be accurately estimated. Exposure categories derived from 
supervisors estimations of past exposure. There was a significant rank correlation between 
this subjective estimation of cumulative exposure and blood manganese levels but not 
urinary levels. On an individual basis, neither blood nor urinary manganese correlated with 
current exposure or with duration of exposure. 
Critique: Well-conducted study with some indication of adverse effect of Mn exposure on 
respiratory system; however, respiratory findings not backed up in Roels et al., 1992.  
 
Sjögren et al., 1996 
 
 Exposure assessment based on exposure times provided by Welders and the reported time 
spent on TIG or MIG welding - the welders appear to have been questioned some years 
after exposure - only 13 welders had been exposed to Mn and had welded for more than 
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100 hours in high alloy Mn steel - small information base.  Exposure to particles in 
breathing zone of welders measured in mid 1970s was 10 mg/m3 for MIG and 1 mg/m3  for 
TIG - fumes from electrodes used contain 2-8% Mn. Study focussed on biological 
monitoring - no relationship between MnB and former Mn exposure. Exposure response 
relationship reported for Al. 
Critique: no detailed investigation of exposure response relationships reported and no 
clear information provided about the levels of Mn exposure that were associated with 
neurobehavioural impairment. 
 
Wang et al., 2006 
 
 Details of exposure measurements not given – not clear whether personal measurements 
of whether respirable or total (welding so probably predominantly respirable anyway); 
routine surveillance data from 1995-2002 showed concs of Mn ranging from 0.1-0.5 mgm-
3.  
Critique: effects not looked at in relation to air Mn – probably not helpful in setting an 
OEL. 
 
Yuan et al., 2006  20 air samples were collected during welding – 10 minute samples collected at height of 
breathing zone – implies not true personal samples - particularly as welders would have 
been wearing helmets – from these samples cumulative Mn exposures were calculated 
based on exposure duration – given the small number of measurements on which these 
estimated cumulative exposures are based, there is considerable uncertainty in their 
reliability. It is not stated how 8 hour TWAs were assessed on the basis on ten minute 
measurements.  
Critique: although the study establishes neurobehavioural effects in the exposed workers 
(with an estimated mean exposure level) it does not provide information as to the level of 
exposures associated with NOAELs and LOAELs – neurobehavioural endpoints are not 
analysed against air Mn or CEI. 
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From the critique of available exposure assessments carried out for the studies utilised by 464 
SCOEL, MAK and ACGIH, it is possible to identify the key studies based on reliability of the 465 
exposure data (although it should be noted that some have other remaining limitations) as 466 
those reported by Roels et al. (1992), Gibbs et al. (1999), Myers et al. (2003a), Bast-Pettersen 467 
et al. (2004) and Ellingsen et al. (2008). 468 
 469 
An important limitation of the above studies is a lack of standardisation of some test 470 
methodology to identify response/effects, especially subtle non-clinical neurotoxicological 471 
effects. For others with standardised methodologies, the interpretation of results can be 472 
subjective. The main finding(s) from the neurological testing carried out as part of the above 473 
studies is detailed in Table 3.  474 
 475 
Table 3 Outcome of neurological testing in key studies. 
Study Occupational 
Group 
Neurological testing End-point 
Roels et al., 1992 
 
Battery workers 
 
 audioverbal short term 
memory test. 
 simple visual reaction time 
measurement over 4 x 2 
minutes using a chronoscope 
(EAP, Issy-les-Moulineaux, 
France). 
 hand steadiness test (3 x 7 
holes, 15 seconds per hole, 
hole diameter 8 to 3-5 mm) 
using the hole tremormeter 
 eye-hand coordination test (2 
x 1 min) using the 
orthokinesimeter of the 
apparatus of Bize (EAP, Issy-
les-Moulineaux, France). 
 
The last three tests were 
performed with the dominant 
hand only. For the eye-hand 
coordination test the subject was 
requested to perform the test at a 
Decline in visual reaction 
time,eye-hand 
coordination, hand 
steadiness.  
 
LOAELs of: 
0.22 mg/m3 (resp) 
0.95 mg/m3 (total) 
Based on increased risk 
of hand tremor. 
Logistic regression 
LOAELs: 
increased risk of 
peripheral tremor (5% 
abnormal response 
increment) when the 
lifetime integrated 
exposure to: 
respirable manganese 
dust exceeded 3.575 
(p=0.029) and to total 
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Table 3 Outcome of neurological testing in key studies. 
Study Occupational 
Group 
Neurological testing End-point 
speed imposed by a metronome (1 
hit/s). 
dust exceeded 0.730 
mg/m³ x years (p=0.054). 
Gibbs et al., 1999 
 
Smelters 
 
 hand steadiness (movemap 
steady; movemap square; 
EAP tremometer) 
 Hand-eye co-ordination (EAP 
Orthokinisimeter) 
 Rapidity of motion (4 choice 
reaction time; finger tapping) 
 mood and 
neuropsychological healh 
questionnaire. 
NOAELs of: 
0.04 mg/m3 (resp) 
0.11 mg/m3 (total) 
Based on lack of 
neurobehavioural 
changes at this level of 
exposure. 
Myers et al., 
2003a 
 
Miners  Maximum forward digit span 
 Maximum backwards digit 
span 
 Digit symbol score 
 Mean reaction time. 
NOAEL of: 
0.2 mg/m3 (total) based 
on lack of 
neurobehavioural 
changes at this level of 
exposure. 
Bast-Pettersen et 
al., 2004 
 
Smelters 
 
 Neuropsychiatric 
questionnaire. 
 Wechslers adult intelligence 
scale. 
 Digit Symbol. 
 Trail-making test. 
 Stroop test. 
 Digit Span. 
 Benton test. 
 Kløve-Matthews Motor 
Steadiness battery. 
 Tremor test. 
 Finger Tapping. 
 Foot Tapping.  
 Dynamometer. 
 Grooved Peg-board test. 
 CATSYS System. 
 Luria-Nebraska Thumb/Finger 
Sequential Touch. 
 Simple Reaction Time test. 
 Hand Eye Coordination test. 
LOAELS of: 
0.036 mg/m3 (resp) 
0.301 mg/m3 (inhal) 
Based on hand tremor. 
Ellingsen et 
al.,2008 
 
Welders 
 
 Questionnaire Q 16. 
 Digit Symbol. 
 Digit Span. 
 Finger Tapping. 
 Foot Tapping. 
LOAELs of : 
0.338 mg/m3 (respirable) 
0.423mg/m3 (total) 
 
NOAELs of: 
0.110 mg/m3 (respirable) 
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Table 3 Outcome of neurological testing in key studies. 
Study Occupational 
Group 
Neurological testing End-point 
 Dynamometer. 
 CATSYS Postural Sway test. 
 CATSYS Maximum Frequency 
test. 
 Kløve–Matthews Static 
Steadiness test. 
0.137 mg/m3 (total) 
 
Based on impaired finger 
Tapping speed  
 476 
 477 
For some of the neurofunctional tests used in the above investigations there are clear NOAELs 478 
and for others there are LOAELs. In the case of LOAELs it is sometimes difficult to appreciate 479 
what the significance of the functional outcome may be, as all the findings are considered 480 
sub-clinical at worst. This is further complicated by the fact that for many of these 481 
neurofunctional tests (e.g. eye-hand coordination) there is little or no normative data in order 482 
to give any changes seen in some of these studies a ‘real-life’ context. Where such data does 483 
exist, such as for visual reaction time, the significant differences in mean RT between control 484 
and exposed groups noted in the study by Roels et al. (1992) are well below those seen with 485 
aging (Spreen et al., 2006). It is therefore difficult to judge whether the non-clinical effects for 486 
visual reaction time described by Roels et al. (1992) would impact on the quality of life of 487 
exposed workers. 488 
 489 
4. Conclusions 490 
The evidence base described above highlights the continued concerns that exist with regard 491 
to several potential adverse health effects that may occur following occupational exposure to 492 
manganese and its inorganic compounds. However, as previously discussed, the most critical 493 
effect for humans associated with chronic low-dose occupational exposures remains some 494 
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subtle non-clinical neurological changes in neuromotor and cognitive functions (shown by 495 
endpoints of tests associated with motor speed and speed of information processing). These 496 
are considered to be the lead effects since they are detectable at the lowest occupational 497 
exposure scenarios available. Hence, any health-based OEL based on these endpoints will be 498 
fully protective against any other possible health effect. It should be noted however, that 499 
interpretation of such subtle changes may be subject to variability both between tests and 500 
within study groups, making precise judgement of associated exposure levels difficult.    501 
 502 
Although all the reviewed studies relating to neurological changes in workers have concluded 503 
that the effects are subtle and non-clinical in nature, it is apparent that there has been a 504 
tendency across regulatory guideline-setting bodies to establish somewhat lower OELs than 505 
those proposed in the review by the IEH (IEH, 2004); this applies to both inhalable and 506 
respirable fractions. The recent OELs proposed by the ACGIH in 2013, the SCOEL in 2011 and 507 
the MAK in 2010 are health-based in nature and relate to establishing a level at which no 508 
effect, even if extremely subtle in nature, would be anticipated to occur over a working 509 
lifetime of 40 years; i.e., they are essentially derivations of a NOAEL.  510 
 511 
Additional evidence from a few new longitudinal investigations has reinforced the suggestion 512 
that subtle neurological effects detected in some repeated studies may not progress once 513 
exposure has ceased or been reduced.  However, it is now clear that not all changes are fully 514 
reversible once established.  515 
 516 
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There is still some question as to the significance of the small non-clinical neurological 517 
changes seen in exposed workers regarding their consequences in terms of both human 518 
health and well-being. That is, it remains unclear if they represent key early markers of an 519 
increased risk of developing more serious neurological disorders (including manganism) in 520 
later life or if they are of little or no consequence to the individual worker. 521 
 522 
Based upon the overall evidence base, it is concluded here that the 8-hr time weighted 523 
averages (TWA) for respirable and inhalable fractions as recommended by the SCOEL in 2011 524 
are the most methodologically-sound, as they are based on the best available studies most 525 
suited to the development of health-based OELs for both respirable and inhalable fractions. 526 
The dose-response characterisation informed by the studies used can be considered to 527 
establish a true human NOAEL for all the neurofunctional endpoints examined in the selected 528 
studies. There is no requirement for short-term exposure limits and as noted in the review by 529 
the IEH (IEH, 2004), there is no reliable biological exposure limit that can be recommended 530 
either based on a health effect or equivalence to an airborne exposure. However, research is 531 
underway to validate useful specific biomarkers of exposure to manganese, in particular for 532 
recent exposure.  533 
 534 
It should be noted that as these recommended OELs are based on very subtle neurofunctional 535 
perturbations which represent the earliest detectable, potentially adverse changes arising 536 
from occupational exposure to manganese adherence to the proposed OELs will therefore 537 
provide protection to workers from all of the other reported effects of occupational exposure 538 
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to manganese and its inorganic compounds. However, it is also important to highlight that 539 
although the recommended OEL will provided protection to all workers, workers in different 540 
fields – alloying, battery production, fertiliser production, mining, welding etc., could be 541 
protected with less stringent OEL’s as the valency, toxicokinetics, solubility, bioavailability of 542 
different inorganic manganese based substances are not the same. Although this lends itself 543 
to the concept of setting ‘sector-specific’ OELs, data is insufficient at the present time for the 544 
derivation of pragmatic OEL’s for each working group sector. 545 
 546 
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Appendix A - Literature search strategy 751 
Web of Science 752 
TOPIC ("BaMnO4" OR "KMnO4" OR "FeMn" OR "Mn2O3" OR "Mn3O4" OR "Mn3O7" OR "Mn5O8" 753 
OR "Mn(NO3)2" OR "Mn(SO4)2" OR "Mn2(SO4)3" OR "MnCl2" OR "MnO" OR "MnO2" OR "MnSO4" 754 
OR "Na3MnO4" OR "SiMn" OR siliconmanganese OR "manganous salt*" OR braunite OR cianciulliite 755 
OR hausmannite OR polianite OR pyrochroite OR pyrolusite OR ramsdellite) AND TOPIC (toxic* OR 756 
exposure* OR manganism OR parkinson* OR poison* OR teratogen* OR mutagen* OR carcinogen* 757 
OR genotox* OR neurotox* OR repro*) AND TOPIC (worker* OR workplace OR occupation*) 758 
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{MnSO4} OR {Na3MnO4} OR {SiMn} OR siliconmanganese OR {manganous salt} OR {manganous 763 
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